NCT00841373View on ClinicalTrials.gov

Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2010

Conditions
Retinal Ischemia
Interventions
PROCEDURE

Panretinal Photocoagulation

Panretinal Photocoagulation treatment

PROCEDURE

Panretinal Photocoagulation and intravitreal injection of ranibizumab

Panretinal photocoagulation and ranibizumab

Trial Locations (1)

02904

Southern New England Retina Associates, Providence

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Southern New England Retina Associates

OTHER